Home/Pipeline/NextGen Screening Test

NextGen Screening Test

Dementia/Alzheimer's Disease

CommercialActive

Key Facts

Indication
Dementia/Alzheimer's Disease
Phase
Commercial
Status
Active
Company

About BioCentra

BioCentra, founded in 2003 and headquartered in Cranbury, New Jersey, with a laboratory in Houston, Texas, is a private diagnostics company. Its core innovation is the TBioScan® technology platform, designed to improve the diagnostic evaluation of mild Traumatic Brain Injury (TBI) for neurologists. The company appears to be in a commercial, revenue-generating stage, offering direct-to-consumer and physician-ordered screening tests for neurological and cardiovascular conditions. BioCentra operates a service-based business model, providing laboratory testing services directly to customers and healthcare professionals.

View full company profile

About BioCentra

BioCentra, founded in 2003 and headquartered in Cranbury, New Jersey, with a laboratory in Houston, Texas, is a private diagnostics company. Its core innovation is the TBioScan® technology platform, designed to improve the diagnostic evaluation of mild Traumatic Brain Injury (TBI) for neurologists. The company appears to be in a commercial, revenue-generating stage, offering direct-to-consumer and physician-ordered screening tests for neurological and cardiovascular conditions. BioCentra operates a service-based business model, providing laboratory testing services directly to customers and healthcare professionals.

View full company profile

Therapeutic Areas